MAVANY TANT: Open Payments
NPI 1457724403 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,732 in 58 payments from 13 companies in 2025. Trend: 2023 $1,856 · 2024 $1,358 · 2025 $1,732
Food & beverage: $1,564Education: $168
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 21 | $428 |
| COLOPLAST CORP | 7 | $270 |
| Astellas Pharma US Inc | 6 | $222 |
| Sumitomo Pharma America, Inc. | 7 | $140 |
| Procept Biorobotics Corporation | 3 | $111 |
| Telix Pharmaceuticals | 1 | $104 |
| Calyxo, Inc. | 1 | $97 |
| Becton, Dickinson and Company | 3 | $94 |
| UROGEN PHARMA, INC. | 2 | $93 |
| Endo USA, Inc. | 3 | $78 |
Products named: ADSTILADRIN, Luja Coude, GEMTESA, AQUABEAM ROBOTIC SYSTEM, ILLUCCIX, Titan, CVAC ASPIRATION SYSTEM, Xtandi.
Industry payments across FL — which companies pay providers there.
